The health claims apply to Cereboost when included at a 200 mg daily dose.
Health Canada has approved Cereboost, an American ginseng ingredient from Naturex (Avignon, France), for cognitive health claims as well as a natural product number (NPN) indicating Health Canada reviewed the ingredient for safety and efficacy.
Cereboost, when included at a 200 mg daily dose, can now tout the following health claims in the Canadian market: 1) helps support cognitive function, 2) helps support cognitive performance, and 3) helps support working memory.
“Our clients will gain multiple benefits from this recognition [by Health Canada],” said Maxence Duprez, sales director for Canada, in a Naturex press release. “They can register their finished products in a shorter period of time and drastically reduce the time-to-market of their launches.”
Read more about current and upcoming regulatory changes in Canada.
Recent animal study finds that Lysoveta may help reduce neonatal brain injury
July 17th 2024A recent animal study found that lysophosphatidylcholine (LPC)-bound omega-3 long-chain polyunsaturated fatty acids (LCPUFAs), marketed as Lysoveta by Aker BioMarine, protected against neonatal hypoxic-ischemic (HI) brain injury in mice.